Anti-Streptococcus pneumoniae Surface Protein A (PspA) Antibody (22004)
Anti-Streptococcus pneumoniae Surface Protein A (PspA) Antibody (22004)
Product No.: 22004
- -
- -
Clone XIR1323 Target Streptococcus pneumoniae Formats AvailableView All Product Type Monoclonal Alternate Names PspA Isotype Mouse IgM Applications ELISA , WB , In-Vivo Protection |
Data
Immunoblotting Immunoblot of recombinant pneumococcal surface protein A (PspA) reacted with #22002. Lanes: 1 and 2, phage lysate from full-length PspA+ clone with and without induction by isopropyl-β-D-thiogalactopyranoside (IPTG), respectively; 3, cell wall extract from pneumococcal type 2 strain D39. See reference 4 below.
- -
- -
Antibody DetailsProduct DetailsReactive Species Streptococcus Pneumoniae Host Species Mouse Immunogen Full-length recombinant pneumococcal surface protein A (PspA) type 2 strain
D39. Product Concentration 1.0 mg/ml Formulation PBS, pH 7.4. State of Matter Liquid Product Preparation Purified by Protein A affinity chromatography Storage and Handling These antibodies are stable for at least one (1) year from date of receipt at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Mouse Monoclonal Antibody specific to Streptococcus pneumoniae surface protein A. Research Area Infectious Disease . IVD Raw Material References & Citations1. McDaniel L. et al. 1984. J Exp Med 160: 386-397. 2. McDaniel L. et al. 1987. Microbial Pathogenesis 3: 249-260. 3. Crain MJ et al. 1990. Infection and Immunity 58: 3293-3299. 4. McDaniel L. et al. 1991. Infection and Immunity 59: 222-228. Technical Protocols  In-Vivo Protection Certificate of Analysis |
Formats Available
- -
- -
Prod No. | Description |
|---|---|
22004 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
